Recombinant Proteins Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Recombinant Protein Manufacturers & Companies. The market is Segmented by Product (Hormone, Growth Factor, Antibody, Enzyme, and Other Products), Application (Research Application, Therapeutic Use, and Biotechnology Industry), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Recombinant Proteins Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Recombinant Proteins Industry Overview

The recombinant protein market is moderately competitive due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, such as Abbvie Inc., Amgen Inc., Bio-Rad Laboratories Inc., Eli Lilly and Company, Merck KGaA, Novo Nordisk AS, Sanofi SA, Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline PLC, Novavax Inc., GigaGen Inc., and Pfizer Inc.

Recombinant Proteins Market Leaders

  1. Eli Lilly and Company

  2. Thermo Fisher Scientific Inc.

  3. Novartis AG

  4. GlaxoSmithKline PLC

  5. Pfizer Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Recombinant Protein Market Concentration